Insider filing
Traded Nov 18 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 4, 2026 · Filed Nov 5, 2026
Idexx Laboratories's Executive Chair of the Board sold $3.18M of Idexx Laboratories shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$3,184,158
Shares × reported transaction price
2 days after results of Nov 2, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $698.55 on Nov 4, 2026, 38% above its 52-week low and 9% below its high, after a 34% rise over the previous 30 trading days
52-week range $504.70 (Sep 11, 2026) to $766.68 (Nov 25, 2025), 74% of the way up, from 251 adjusted closes. 30 trading days earlier: $522.02 on Sep 23, 2026. Describes the past only, not a forecast
RSI 79, 22% above its 200-day average, 29% above its 50-day average, 9% below the 52-week high, 20-day volatility 74% a year, against the S&P 500: +37 points over 1 month, +19 points over 3 months, +16 points over 6 months
From the adjusted closes up to Nov 4, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.2% | +2.6% | +1.6% |
Past results only. Not a forecast.
Insider filing
Traded Nov 18 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Nov 18 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Nov 18 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade. A share price line is a session where the close moved at least 10% and four times its usual daily change.
The company's last weighty Form 8-K report up to this date: reported its results, 2 days earlier (Nov 2, 2026).